PeptidePicker
Get Started
Home/Peptides/Tesamorelin
Growth HormoneFDA Approved

Tesamorelin

Also known as: Egrifta

An FDA-approved GHRH analog with extraordinary specificity for reducing visceral adipose tissue. Originally designed for HIV-associated lipodystrophy.

Dr. Sarah Mitchell

Reviewed by Dr. Sarah Mitchell, PharmD, BCPS

Lead Researcher · 12+ years in peptide therapeutics

Half-Life

~26–38 minutes

Typical Dose

1–2 mg daily

Administration

Subcutaneous injection

Mechanism of Action

Potent GHRH agonist that stimulates physiological GH release, specifically targeting visceral fat reduction and improving hepatic steatosis.

Key Research Areas

growth hormonevisceral fatFDA approvedGHRHlipodystrophy

Frequently Asked Questions

What is Tesamorelin?▾
An FDA-approved GHRH analog with extraordinary specificity for reducing visceral adipose tissue. Originally designed for HIV-associated lipodystrophy.
How does Tesamorelin work?▾
Potent GHRH agonist that stimulates physiological GH release, specifically targeting visceral fat reduction and improving hepatic steatosis.
What is the recommended dosage for Tesamorelin?▾
The typical research dosage is 1–2 mg daily, administered via Subcutaneous injection. Dosage protocols vary by study and should be determined by a qualified healthcare professional.
What is the half-life of Tesamorelin?▾
The half-life of Tesamorelin is approximately ~26–38 minutes. This affects dosing frequency and timing in research protocols.
Is Tesamorelin FDA approved?▾
Yes, Tesamorelin is FDA approved for specific medical indications. Consult your physician for proper medical guidance.

Research Disclaimer

The information provided about Tesamorelin is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.

Related Peptides in Growth Hormone

MK-677

Ibutamoren · MK677

Sermorelin

GRF 1-29 · Geref

Ipamorelin

NNC 26-0161

CJC-1295

Mod GRF(1-29) · Modified GRF

Back to All PeptidesFind Your Peptide — Take the Quiz